We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Bacillus Species Infection in Patients With Hematologic Neoplasia

James E. Pennington, MD; Nuala D. Gibbons, BM, BCh; John E. Strobeck, MD; Gary L. Simpson, MD, PhD; Richard L. Myerowitz, MD
JAMA. 1976;235(14):1473-1474. doi:10.1001/jama.1976.03260400039027.
Text Size: A A A
Published online


THE USE of intensive chemotherapy for patients with hematologic neoplasia has produced a rapidly growing population of immunosuppressed patients at high risk for opportunistic infections. Until recently, only one case of infection with the aerobic, Gram-positive, spore-forming rods of the genus Bacillus has been reported in this group of patients.1 Since 1971, however, Bacillus species infection has been reported in three such patients,2,3 all with fatal outcome. None of these Bacillus species were B anthracis. The present report identifies two further cases of fatal Bacillus infection in patients with hematologic neoplasia and outlines some important clinical considerations when this organism is encountered.

Report of Cases 

Case 1.—  A 56-year-old woman with leukemic reticuloendotheliosis was admitted to the Peter Bent Brigham Hospital because of a fever and cough of two days' duration. Current medications were cyclophosphamide and prednisone. On physical examination, her temperature was 38.6 C, she appeared dyspneic,


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.